• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Meetings
    • 2026 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2026 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2026 Poster Presentations

2026 Poster Presentations

 

← Back to Previous Page

 

P144: STAGED PETROCLIVAL MENINGIOMA RESECTION: PREDICTORS OF MOTOR AND GAIT OUTCOMES
J. Manuel Revuelta-Barbero, MD, PHD; Hithardhi Duggireddy, MS; Rommi Kashlan; Thomas McCaffery, BS; Karen Salmeron-Moreno, MD; Karthik Papisetty, BA; Gustavo Pradilla, MD; Tomas Garzon-Muvdi, MD, MSc; Emory University

Background: Motor and gait deficits are common in patients with petroclival meningioma (PCM), significantly compromising independence and quality of life. Common symptomatic outcomes include weakness, sensory compromise, gait deficits, dysarthria, and dysphagia. Surgical management with either single or two-staged resection must balance oncologic control against those functional outcomes. Understanding baseline burden, longitudinal recovery, and predictors of motor/gait symptom resolution is critical for surgical decision-making. 

Objective: To compare motor and gait outcomes following single-staged versus two-staged PCM resection to identify predictors of functional outcomes and persistent dysfunction at 12 months.  

Methods: A retrospective analysis was conducted on 49 patients who underwent PCM resection. 41 patients underwent single-staged resection (83.7%) and 8 underwent two-staged resection (16.3%). Baseline variables included age, tumor volume, WHO grade, Karnofsky Performance Status (KPS), modified Rankin Scale (mRS), and cranial nerve VII (CN VII) dysfunction. Motor/gait symptoms (weakness, sensory compromise, gait deficits, dysarthria, dysphagia) were assessed at baseline and 3, 6, and 12 months. Symptom prevalence, burden (sum of symptoms at timepoint), and 12-month resolution rates were calculated. Group comparisons used Mann–Whitney U and Fisher’s exact tests. Logistic regression, feature-importance analysis, and risk stratification (tumor volume, age, and preoperative burden) identified predictors of outcome. 

Results: Two-staged patients had significantly larger tumors (71.5±58.1 vs 23.0±22.6 cm³, p=0.002) and worse baseline function (mRS 2.6 vs 1.7, p=0.009). Baseline CN VII dysfunction was more prevalent in the two-stage cohort (62.5% vs 9.8%, p=0.003). Preoperative motor/gait symptoms were more common with two-stage plans: weakness 50% vs 17.5%, sensory compromise 75% vs 25%, gait deficit 62.5% vs 45%; dysarthria and dysphagia were present in two-stage patients but rare/absent in single-stage cases. 

By 12 months, single-stage patients showed meaningful recovery across domains: weakness 29.7% to 21.6%, sensory compromise 40.5% to 21.6%, gait deficit 45% to 21.6%; dysarthria and dysphagia achieved >80% resolution. In contrast, two-staged patients had persistent or worsening deficits, with weakness 100%, sensory compromise 100%, and gait deficit 66.7% at 12 months. Resolution favored single-staged for gait deficit (80% vs 20%) and sensory compromise (50% vs 0%); dysphagia recovery was high in both groups, whereas dysarthria largely persisted after staged surgery. Predictive modeling ranked tumor volume (importance 0.35), preoperative burden (0.28), and age (0.18) as the strongest predictors of poor outcome. Logistic regression confirmed that greater baseline symptom and tumor burden increased the risk of persistent dysfunction at 12 months, while surgical staging was not independently predictive after adjustment for complexity. Risk stratification indicated that low-risk patients (≤2 baseline symptoms, smaller tumors) achieved >80% favorable outcomes with single-stage surgery, whereas high-risk patients (≥3 symptoms, large tumors, age >70) had limited recovery regardless of strategy. 

Conclusions: Motor and gait dysfunctions are more severe and persistent in patients undergoing two-stage resections, reflecting higher baseline burden and tumor complexity. One-stage surgery was associated with substantial functional recovery, while two-stage cases demonstrated limited improvement. Tumor volume, preoperative burden, and age are the dominant predictors of outcome. Integrating these variables into decision frameworks may optimize patient selection for staged resections, refine surgical planning, and guide rehabilitation.

View Poster

 

← Back to Previous Page

Copyright © 2026 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved